Competition | Regulation | Litigation
Blogs
06-04-2022
Seven new tips for businesses in consumer sales
ACM is still actively enforcing compliance with consumer rules. This blog addresses the latest developments and provides seven tips. Read more >
04-04-2022
Monopolies and dominant positions: focus on pharma & big tech
The Commission and ACM remain critical of pharma and big tech companies. In this blog we address the developments regarding the prohibition on abuse of dominant positions. Read more >
01-04-2022
Agri-food: Unfair Commercial Practices Act curbs purchasing power; more opportunities for sustainability agreements
A new era is dawning in the agri-food sector. ACM has been given a new enforcement instrument to take action against the purchasing power of retailers, and the sector will have more opportunities for sustainability initiatives. Read more >
29-03-2022
New rules for distribution agreements
Beware of dual distribution and restrictions on price comparison sites. Read more >
28-03-2022
Franchise and competition – The new Vertical Block Exemption Regulation
The new Vertical Block Exemption Regulation will enter into force on 1 June 2022. This blog addresses the main changes for franchise agreements. Read more >
21-03-2022
Will the NZa merger test be changed in 2022? Abolition of healthcare-specific merger test is preferable
The NZa merger test was and remains superfluous. The NZa and ACM would be better advised to focus on real problems in the healthcare sector. Read more >
16-03-2022
Competition law and the pharma sector: access to (expensive) medicines on the European and national agenda
Dutch government to take action against expensive medicines, competition authorities target pharmaceutical companies, and NZa provides more clarity on add-on medicines. Read more >